Personalis combines expertise both in the technology of sequencing and in interpretation, with an extensive history of peer reviewed publication and commercial success. Broad adoption of medical genome interpretation will require accuracy befitting regulatory approval, both in variant detection and interpretation. More than half of the founding team are MDs, and this reflects the company's commitment to serious medically-focused results, at quality standards eventually suitable for regulatory approval and insurance reimbursement. The team includes experienced PhD scientists, who know that the research community also cares deeply about accuracy, thoroughly substantiated and peer-reviewed. Personalis has exclusively licensed key intellectual property originating in the labs of the founders. Lastly, the Personalis team includes business people with decades of experience in genetic analysis, who know that the democratization of genome sequencing will also require high-quality customer support for interpretation, lab by lab, genome after genome.
Company Growth (employees)
Menlo Park, US
Size (employees)
83 (est)+6%
Personalis was founded in 2011 and is headquartered in Menlo Park, US

Key People at Personalis

Carol J. Tillis

Carol J. Tillis

Vice President Finance and Administration
Christian Haudenschild

Christian Haudenschild

Senior Director of Genomic Services
Michael Fitzpatrick

Michael Fitzpatrick

Vice President Worldwide Sales

Personalis Office Locations

Personalis has offices in Menlo Park, West Wickham
Menlo Park, US (HQ)
1330 O'Brien Dr
West Wickham, GB
Squires House, 205A High Street

Personalis Metrics

Summary Metrics

Founding Date


Total Funding

$75 m

Latest funding size

$22 m

Time since last funding

over 3 years


Personalis's latest funding round in October 2013 was reported to be $22 m. In total, Personalis has raised $75 m

Personalis Online Presence

Personalis News

Personalis Company Life

You may also be interested in